文献速递产科母胎医学

妊娠期抗抑郁药使用与严重心脏畸形:丹麦登记研究

Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
PubMed 文献 · BJOG · 2021-06-22

结果显示文拉法辛暴露与严重心脏畸形风险升高相关,但绝对风险较低,且存在左心发育不良综合征聚集现象。

要点

  • 文拉法辛暴露与严重心脏畸形风险升高相关(PR 2.13,95%CI 0.89-5.13)。
  • 文拉法辛暴露者左心发育不良综合征粗PR为17.4(95%CI 6.41-47.2)。
  • 文拉法辛暴露可作为高危妊娠标志,可考虑胎儿超声心动图检查。

核心结论

  • 妊娠期文拉法辛暴露与严重心脏畸形风险升高相关,但绝对风险较低。

主要发现

  • 文拉法辛暴露者严重心脏畸形PR为2.13(95%CI 0.89-5.13),其他心脏畸形PR为1.73(95%CI 1.08-2.77)。
  • 文拉法辛暴露者左心发育不良综合征粗PR为17.4(95%CI 6.41-47.2),均未活产。
  • 左心发育不良综合征绝对风险增加4.4/1000,需伤害人数为225。
  • 选择性5-羟色胺再摄取抑制剂暴露者严重心脏畸形PR为1.09(95%CI 0.52-2.30),其他心脏畸形PR为1.38(95%CI 1.00-1.92)。

临床怎么用

  • 文拉法辛暴露可作为高危妊娠标志,可考虑胎儿超声心动图检查。

局限性

  • 潜在机制包括直接效应或适应证混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Studies restricted to live births may underestimate severe teratogenic effects. We address the limitation by including data from both prenatal and postnatal diagnoses of cardiac malformations. DESIGN: Register-based study. SETTING: Denmark. POPULATION: 364 012 singleton pregnancies from 2007 to 2014. METHODS: We used data from five nationwide registries. Exposure to antidepressants was measured using redeemed prescriptions. MAIN OUTCOME MEASURES: Pregnancies with cardiac malformations that end in miscarriage, termination, stillbirth, postnatal death or cardiac surgery <1 year of birth were classified as severe cardiac malformations (SCM). Propensity scores with adjusted prevalence ratios (PRs) were calculated. RESULTS: SCM were reported in 972 of 364 012 pregnancies overall and in 16 of 4105 exposed. For venlafaxine, the PR for SCM was 2.13 (95% confidence interval [CI] 0.89-5.13), 1.73 (95% CI 1.08-2.77) for other cardiac malformations, and there was a cluster of hypoplastic left heart syndromes (HLHS) (crude PR 17.4 [95% CI 6.41-47.2]), none of which ended in a live birth. For HLHS, the absolute risk increase was 4.4/1000 and the number needed to harm was 225. For selective serotonin reuptake inhibitors, the PRs were 1.09 (95% CI 0.52-2.30) and 1.38 (95% CI 1.00-1.92) for SCM and other cardiac malformations, respectively. CONCLUSIONS: Pregnancy exposure to venlafaxine is associated with an increased risk of severe cardiac malformations but with a low absolute risk. Potential mechanisms include direct effects or confounding by indication. Venlafaxine exposure is a marker for risk pregnancies for which fetal echocardiography may be considered. TWEETABLE ABSTRACT: Exposure to venlafaxine is associated with an increased risk of cardiac malformations but with a low absolute risk.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Kolding L, Ehrenstein V, Pedersen L, et al. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG. 2021. PMID: 34036715. doi:10.1111/1471-0528.16772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。